
Sign up to save your podcasts
Or


In this episode Professor Harries discuss whether RNA Splicing meets the criteria of a hallmark of aging. To qualify it should i) manifest during normal aging ii) its aggravation should accelerate aging and iii) it amelioration should slow or reverse aging. Prof Harries goes through each of these criteria with respect to RNA splicing.
Lorna Harries is Professor of Molecular Genetics at the University of Exeter College of Medicine and Health where she leads the RNA-mediated disease mechanisms group. Her group has interests in messenger RNA processing and epigenetic gene regulation in the context of ageing and chronic disease.
She is a Co-Founder & the Chief Scientific Officer for SENISCA (www.senisca.com), a senotherapeutics company. Her team were the first to report dysregulation of alternative splicing as a new, and druggable, hallmark of ageing. With that, let me start the interview.
Professor Harries site at University of Exeter
https://medicine.exeter.ac.uk/people/profile/index.php?web_id=Lorna_Harries
Senisca home page
https://www.senisca.com/
If you would like to support our channel, we’d love a coffee ☕…thank you! https://www.buymeacoffee.com/mhealthspan
You can also find us on YouTube at https://www.youtube.com/c/modernhealthspan
15% off Bulletproof products at https://www.bulletproof.com/ with discount code HEALTHSPAN15.
Renue By Science 10% discount code MHS at https://renuebyscience.com/all-products-2/
10% off all products at DoNotAge with code MODERNHEALTHSPAN at https://donotage.org/
By Modern Healthspan3.6
77 ratings
In this episode Professor Harries discuss whether RNA Splicing meets the criteria of a hallmark of aging. To qualify it should i) manifest during normal aging ii) its aggravation should accelerate aging and iii) it amelioration should slow or reverse aging. Prof Harries goes through each of these criteria with respect to RNA splicing.
Lorna Harries is Professor of Molecular Genetics at the University of Exeter College of Medicine and Health where she leads the RNA-mediated disease mechanisms group. Her group has interests in messenger RNA processing and epigenetic gene regulation in the context of ageing and chronic disease.
She is a Co-Founder & the Chief Scientific Officer for SENISCA (www.senisca.com), a senotherapeutics company. Her team were the first to report dysregulation of alternative splicing as a new, and druggable, hallmark of ageing. With that, let me start the interview.
Professor Harries site at University of Exeter
https://medicine.exeter.ac.uk/people/profile/index.php?web_id=Lorna_Harries
Senisca home page
https://www.senisca.com/
If you would like to support our channel, we’d love a coffee ☕…thank you! https://www.buymeacoffee.com/mhealthspan
You can also find us on YouTube at https://www.youtube.com/c/modernhealthspan
15% off Bulletproof products at https://www.bulletproof.com/ with discount code HEALTHSPAN15.
Renue By Science 10% discount code MHS at https://renuebyscience.com/all-products-2/
10% off all products at DoNotAge with code MODERNHEALTHSPAN at https://donotage.org/

7,206 Listeners

4,998 Listeners

5,406 Listeners

293 Listeners

716 Listeners

4,892 Listeners

3,484 Listeners

9,221 Listeners

1,816 Listeners

1,099 Listeners

290 Listeners

233 Listeners

160 Listeners

184 Listeners

1,182 Listeners